DoseMe
- Company typePrivate
- Founded2012
- HeadquartersBrisbane, Australia
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
DoseMe firmographics
Firmographics- Name
- DoseMe
- Legal name
- DoseMe Pty Ltd
- Website
- https://doseme-rx.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
DoseMe industry classification
Industry- Product category
- Clinical Decision Support Software
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Clinical Pharmacology & Pharmacometrics (Modeling & Simulation) (HLAIALAG)
- akta.pro secondary industries
- Medication Analytics, Outcomes & Cost Optimization (HLACAKAL), Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools (HLACAKAH), Medication Therapy Management (MTM) & Clinical Pharmacy Services (HLAFALAH)
Keywords
Where DoseMe is headquartered
LocationHeadquarters
- HQ city
- Brisbane
- HQ country
- Australia
- HQ region
- Oceania
Offices2 records
Markets served
DoseMe business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Software Licensing (DoseMeRx): Licensed software product sold to healthcare organizations. Pricing based on number of sites in hospital system and type of access required (web-based standalone or EHR-integrated). Includes custom integration by DoseMeRx engineering team, virtual or on-site training, 24/7 customer support, and access to clinical advisory board resources.
- DoseMe Analytics: Analytics dashboard product providing real-time clinical data visualization. Sold as part of integrated license options or standalone subscription.
- EHR Integration Services: Custom integration engineering services for Epic, Cerner, and pharmacy surveillance software implementations. Included as part of integrated license options.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Web-based Solution |
| Subscription | Multi-year contract | EHR Integration (Epic, Cerner) |
| Subscription | Multi-year contract | Pharmacy Surveillance Integration |
Go-to-market motion4 records
Distribution channels8 records
Marketing channels7 records
DoseMe product offering
Product offeringCore offering
DoseMe sells DoseMeRx, a Bayesian dosing software platform that uses clinically-validated pharmacokinetic/pharmacodynamic models combined with individual patient characteristics (age, height, weight, sex, genotype) and drug concentration data to calculate patient-specific, individualized drug doses in seconds. The platform covers drugs with narrow therapeutic windows across infectious diseases, oncology, transplant, cardiovascular, biologics, and pediatrics, and is offered as a web-based solution or embedded within Epic and Cerner EHRs. DoseMe Analytics, an add-on module, provides real-time dashboards for dosing performance, protocol compliance, and outcomes tracking.
Product overview
DoseMe offers DoseMeRx as its core Bayesian dosing platform, supplemented by DoseMe Analytics as an embedded analytics module. DoseMeRx provides model-informed precision dosing (MIPD) software that calculates patient-specific drug doses using clinically-validated pharmacokinetic/pharmacodynamic models combined with individual patient data. The platform is available via web-based access or through EHR integrations with Epic and Cerner. DoseMe Analytics provides real-time dashboards and reporting capabilities embedded within the core platform.
Differentiator
Problem solved
Functional benefit
Brands
- DoseMeRx: The primary Bayesian dosing software platform providing precision dosing calculations for clinicians
- DoseMe Analytics
Products and services
- DoseMeRx Bayesian dosing software platform that calculates patient-specific drug doses using clinically-validated pharmacokinetic/pharmacodynamic models combined with patient characteristics, drug concentrations, and genotype. Sold to hospitals and health systems for precision dosing of narrow therapeutic index drugs across infectious diseases, oncology, transplant, cardiovascular, biologics, and pediatrics. Available as a web-based solution or embedded within Epic and Cerner EHRs.
- DoseMe Analytics Analytics dashboard module that provides real-time visualization of dosing data, AUC vs trough outcomes, patient risk, time to therapeutic targets, daily dosages, drug model usage, and protocol compliance. Sold as a standalone subscription or bundled with DoseMeRx to clinical pharmacy teams monitoring prescribing practices across health systems.
Quantifiable outcome
- 70% decrease in rate of kidney injury reported by A.C. Camargo Cancer Center
- +4 more outcomes
Companies that use DoseMe
Customer profileNamed customers21 records
Segments7 records
Ideal customer profiles4 records
DoseMe technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
AI capability2 records
Feature9 records
DoseMe partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core and minor.
- FirstlinecoreDoseMe acquired Firstline, a leading mobile-first clinical decision support platform for infectious disease treatment guidance. Firstline enables clinicians to rapidly access local, evidence-based treatment guidance, susceptibility patterns, and antimicrobial stewardship resources. The combination creates a unified platform from therapy selection through personalized dosing for the global fight against infectious disease.
- Wolters KluwerminorJoint webinars on vancomycin Bayesian dosing co-presented with Wolters Kluwer. Collaboration for educational content around precision dosing and 2020 vancomycin guidelines.
- CernercoreIntegration partnership with Cerner Millennium EHR. DoseMeRx is embedded within the Cerner platform for seamless in-workflow dosing decisions. Automatic patient data loading eliminates manual entry. Companies co-presented at Cerner Health Conference 2017.
- EpiccoreIntegration partnership with Epic EHR through Epic App Orchard. DoseMeRx has increased FHIR power in Epic's App Orchard for enhanced interoperability. Embedded integration provides seamless access to dosing recommendations within Epic workflows.
- Dot.libminorExpanded licensing agreement with Dot.lib for distribution of DoseMeRx content and platform access.
- Keegan Mason & AssociatesminorCollaboration to advance clinical outcomes and antimicrobial stewardship specifically targeting rural and community hospitals in the United States.
- DaiKnowminorPartnership to advance model-informed precision dosing in India market. Expanding DoseMe's global footprint into South Asia.
- IscientiaminorIscientia added DoseMeRx to expand portfolio and revolutionize healthcare practices.
- Primum PharmaminorExpanded reseller agreement with Primum Pharma into the MENA (Middle East and North Africa) market. Also covers Turkey distribution.
- Albertina icome PrahaminorPartnership with Albertina icome Praha for distribution and reseller services in Czech Republic and Slovakia as demand for precision dosing increases in the region.
- Bainbridge Health PartnersminorPartnership to expand medication management capabilities to health systems through DoseMe integration.
- HealixminorStrategic partnership with Healix for precision dosing services.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
DoseMe competitors and assessment
Company assessmentDirect peers
- Insight Rx: Insight Rx is a direct competitor offering a Bayesian dosing platform for precision dosing of vancomycin, aminoglycosides, and other therapeutic agents in hospital settings. It targets similar clinical pharmacist customers and overlaps materially on drug model coverage and EHR integration strategy.
- Sanford Guide: Sanford Guide is a leading antimicrobial stewardship content reference integrated with DoseMeRx but also sold independently to clinicians. It is comparable because it provides treatment-guidance content that competes directly with DoseMe's recent Firstline acquisition and overlaps on infectious-disease decision support.
- PrecisePK: PrecisePK is a direct peer offering Bayesian dosing software for clinical pharmacokinetic monitoring in hospitals, with comparable use cases in vancomycin AUC dosing and aminoglycoside TDM. It is a frequently cited alternative to DoseMeRx in clinical pharmacy literature and procurement decisions.
Broad incumbents
- Elsevier (Clinical Pharmacology / ClinicalPath): Elsevier's Clinical Pharmacology and ClinicalPath products provide drug reference and clinical decision support content used by hospitals alongside dosing workflows. Comparable as a broader incumbent whose drug content and CDS suite overlaps thematically with DoseMe's clinical evidence and dosing recommendations.
- First Databank (FDB): First Databank, an Hearst Health company, is a broad incumbent in drug knowledge and clinical decision support, providing drug reference data and screening tools embedded in EHR workflows. It is comparable as an adjacent clinical-content provider whose drug data and CDS modules could overlap with DoseMe's dosing recommendations over time.
- Tabula Rasa HealthCare (Quantal Health): Tabula Rasa HealthCare (now Quantal Health) is a broader medication management and pharmacy services incumbent that has historically offered precision dosing capabilities. It operates at a larger scale across PACE and senior care populations, partially overlapping with DoseMe's home infusion and elderly patient use cases.
- Wolters Kluwer (Sentri7 / Pharmacy OneSource): Wolters Kluwer operates Sentri7 and Pharmacy OneSource, which are integrated with DoseMeRx but also offer broader pharmacy surveillance and clinical decision support. Comparable as an incumbent with overlapping antimicrobial stewardship and pharmacy content capabilities across the same hospital customer base.
- McKesson (Pharmacy Solutions / Macro Helix): McKesson offers pharmacy and medication management solutions at scale to hospital systems, including antimicrobial stewardship programs. Comparable as a broad incumbent whose commercial reach and prior stewardship program launches (where DoseMe's CEO previously worked) place it in adjacent competition for hospital pharmacy IT budgets.
Regional players
- PharMerica / BrightSpring Health Services: BrightSpring Health Services and its pharmacy subsidiaries (including PharMerica) serve long-term care, home infusion, and specialty pharmacy populations with medication management services. Comparable as a regional US-based player whose clinical pharmacy and home infusion customer base overlaps with DoseMe's home infusion and PACE use cases.
Emerging players
- VigiLanz: VigiLanz is a pharmacy surveillance platform that integrates with DoseMeRx and offers adjacent antimicrobial stewardship and clinical surveillance capabilities. It is comparable as a peer/partner that competes for hospital pharmacy IT wallet share while enabling DoseMe distribution through its installed base.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
DoseMe social profiles
Digital presenceDoseMe compliance and trust
Trust signalCompliance5 records
DoseMe financial estimates
Financial estimateRevenue estimate
Valuation estimate
DoseMe leadership team
Management profileNumber of profiles
Profiles7 records
DoseMe subsidiaries and ownership
Company hierarchySubsidiaries1 record
DoseMe funding detail
Funding detailFunding overview
Funding rounds2 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
DoseMe M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about DoseMe
What does DoseMe do?
DoseMe sells DoseMeRx, a Bayesian dosing software platform that uses clinically-validated pharmacokinetic/pharmacodynamic models combined with individual patient characteristics (age, height, weight, sex, genotype) and drug concentration data to calculate patient-specific, individualized drug doses in seconds. The platform covers drugs with narrow therapeutic windows across infectious diseases, oncology, transplant, cardiovascular, biologics, and pediatrics, and is offered as a web-based solution or embedded within Epic and Cerner EHRs. DoseMe Analytics, an add-on module, provides real-time dashboards for dosing performance, protocol compliance, and outcomes tracking.
Is DoseMe a public or private company?
DoseMe is a private company. It is classified as private equity controlled and is currently operating.
When was DoseMe founded?
DoseMe was founded in 2012. It employs 11 to 50 people.
Where is DoseMe based?
DoseMe is headquartered in Brisbane, Australia, in the Oceania region.
How does DoseMe make money?
Three revenue lines are on record. Software Licensing (DoseMeRx) is the primary driver. The others are doseMe Analytics and EHR Integration Services.
Who are DoseMe's main competitors?
Direct peers on record are Insight Rx, Sanford Guide and PrecisePK. Broad incumbents are Elsevier (Clinical Pharmacology / ClinicalPath), First Databank (FDB), Tabula Rasa HealthCare (Quantal Health), Wolters Kluwer (Sentri7 / Pharmacy OneSource) and McKesson (Pharmacy Solutions / Macro Helix). PharMerica / BrightSpring Health Services is listed as a regional player. VigiLanz is listed as an emerging player.
Does DoseMe have an API?
No public API is recorded for DoseMe.
What industry is DoseMe in?
DoseMe's product category is Clinical Decision Support Software. Its primary akta.pro industry code is HLAIALAG, Clinical Pharmacology & Pharmacometrics (Modeling & Simulation), with a secondary code of HLACAKAL, Medication Analytics, Outcomes & Cost Optimization. Its SIC code is 7372.